Corbus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.

About CRBP

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. 

CEO
Yuval Cohen
CEOYuval Cohen
Employees
19
Employees19
Headquarters
Norwood, Massachusetts
HeadquartersNorwood, Massachusetts
Founded
2009
Founded2009
Employees
19
Employees19

CRBP Key Statistics

Market cap
413.53M
Market cap413.53M
Price-Earnings ratio
-3.78
Price-Earnings ratio-3.78
Dividend yield
Dividend yield
Average volume
287.10K
Average volume287.10K
High today
$39.99
High today$39.99
Low today
$35.16
Low today$35.16
Open price
$35.42
Open price$35.42
Volume
235.06K
Volume235.06K
52 Week high
$49.87
52 Week high$49.87
52 Week low
$3.03
52 Week low$3.03
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.